Yuet-Kin Leung
Concepts (428)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Estrogen Receptor beta | 17 | 2019 | 54 | 3.610 |
Why?
| Prostatic Neoplasms | 15 | 2022 | 394 | 2.700 |
Why?
| Endocrine Disruptors | 6 | 2024 | 30 | 2.610 |
Why?
| Phenols | 9 | 2021 | 80 | 2.110 |
Why?
| Benzhydryl Compounds | 9 | 2021 | 67 | 2.100 |
Why?
| Epigenesis, Genetic | 10 | 2024 | 378 | 1.960 |
Why?
| Environmental Pollutants | 4 | 2024 | 91 | 1.690 |
Why?
| Gene Expression Regulation, Neoplastic | 9 | 2024 | 828 | 1.280 |
Why?
| Estrogens | 7 | 2020 | 228 | 1.270 |
Why?
| DNA Methylation | 12 | 2019 | 550 | 1.220 |
Why?
| Cell Line, Tumor | 21 | 2024 | 1416 | 1.060 |
Why?
| Signal Transduction | 12 | 2021 | 1622 | 1.010 |
Why?
| Estradiol | 9 | 2021 | 225 | 1.000 |
Why?
| Carcinoma, Hepatocellular | 2 | 2024 | 193 | 0.950 |
Why?
| Breast Neoplasms | 7 | 2016 | 1179 | 0.910 |
Why?
| Cell Movement | 4 | 2020 | 249 | 0.900 |
Why?
| beta Catenin | 1 | 2024 | 102 | 0.890 |
Why?
| Wnt Signaling Pathway | 1 | 2024 | 92 | 0.890 |
Why?
| Endocrine System | 1 | 2023 | 16 | 0.890 |
Why?
| Receptors, Androgen | 2 | 2022 | 46 | 0.860 |
Why?
| Liver Neoplasms | 2 | 2024 | 328 | 0.830 |
Why?
| Mice, Knockout | 2 | 2024 | 846 | 0.810 |
Why?
| Occupational Exposure | 3 | 2021 | 121 | 0.800 |
Why?
| Antineoplastic Agents | 5 | 2021 | 1186 | 0.790 |
Why?
| Cell Proliferation | 10 | 2022 | 1013 | 0.780 |
Why?
| Environmental Exposure | 7 | 2024 | 199 | 0.750 |
Why?
| Protein Kinase Inhibitors | 5 | 2023 | 206 | 0.750 |
Why?
| Toxicity Tests | 1 | 2020 | 54 | 0.730 |
Why?
| Mammary Neoplasms, Experimental | 2 | 2017 | 121 | 0.660 |
Why?
| Humans | 58 | 2024 | 50208 | 0.650 |
Why?
| Animals | 26 | 2024 | 13246 | 0.630 |
Why?
| Chromosomes, Human, X | 1 | 2018 | 19 | 0.620 |
Why?
| Leukemia, Myeloid, Acute | 3 | 2023 | 185 | 0.570 |
Why?
| Protective Clothing | 1 | 2015 | 6 | 0.530 |
Why?
| Firefighters | 1 | 2015 | 4 | 0.530 |
Why?
| Estrogen Antagonists | 1 | 2015 | 21 | 0.530 |
Why?
| Antineoplastic Agents, Hormonal | 2 | 2014 | 48 | 0.520 |
Why?
| Transcriptional Activation | 4 | 2013 | 121 | 0.490 |
Why?
| Response Elements | 2 | 2013 | 29 | 0.490 |
Why?
| MicroRNAs | 3 | 2016 | 355 | 0.470 |
Why?
| Prostate | 6 | 2016 | 117 | 0.460 |
Why?
| Sp1 Transcription Factor | 2 | 2024 | 21 | 0.440 |
Why?
| Prenatal Exposure Delayed Effects | 4 | 2021 | 185 | 0.440 |
Why?
| Promoter Regions, Genetic | 4 | 2019 | 475 | 0.440 |
Why?
| Exons | 1 | 2013 | 95 | 0.430 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 129 | 0.430 |
Why?
| Apoptosis | 4 | 2022 | 1112 | 0.420 |
Why?
| Rats | 11 | 2021 | 3299 | 0.420 |
Why?
| Male | 31 | 2024 | 25399 | 0.410 |
Why?
| Female | 28 | 2024 | 26635 | 0.410 |
Why?
| CpG Islands | 7 | 2019 | 107 | 0.400 |
Why?
| Diet, High-Fat | 4 | 2021 | 220 | 0.390 |
Why?
| Proto-Oncogene Proteins c-ret | 2 | 2022 | 33 | 0.370 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2019 | 203 | 0.370 |
Why?
| Muscle Proteins | 1 | 2013 | 312 | 0.370 |
Why?
| Receptors, Estrogen | 4 | 2019 | 131 | 0.350 |
Why?
| Adenocarcinoma | 2 | 2011 | 397 | 0.350 |
Why?
| Pyrimidines | 2 | 2022 | 193 | 0.340 |
Why?
| Spermatogenesis | 2 | 2021 | 9 | 0.340 |
Why?
| RNA, Messenger | 5 | 2022 | 1108 | 0.330 |
Why?
| HEK293 Cells | 5 | 2021 | 224 | 0.320 |
Why?
| Maternal Exposure | 2 | 2021 | 86 | 0.320 |
Why?
| Air Pollutants, Occupational | 2 | 2020 | 17 | 0.320 |
Why?
| Orphan Nuclear Receptors | 2 | 2019 | 15 | 0.320 |
Why?
| Dose-Response Relationship, Drug | 6 | 2021 | 1378 | 0.310 |
Why?
| fms-Like Tyrosine Kinase 3 | 3 | 2023 | 16 | 0.310 |
Why?
| Transcription, Genetic | 4 | 2013 | 369 | 0.310 |
Why?
| Epigenomics | 2 | 2019 | 68 | 0.290 |
Why?
| Mass Spectrometry | 2 | 2024 | 301 | 0.290 |
Why?
| Mutation | 5 | 2023 | 1294 | 0.290 |
Why?
| Protein Isoforms | 4 | 2013 | 119 | 0.290 |
Why?
| Mice | 6 | 2024 | 5759 | 0.280 |
Why?
| Gene Expression Profiling | 5 | 2015 | 1037 | 0.270 |
Why?
| Phosphorylation | 5 | 2021 | 534 | 0.270 |
Why?
| Pregnancy | 8 | 2023 | 2604 | 0.260 |
Why?
| Lung Neoplasms | 3 | 2022 | 605 | 0.260 |
Why?
| Cytochrome P-450 CYP1A1 | 1 | 2005 | 26 | 0.250 |
Why?
| Androgens | 2 | 2022 | 69 | 0.250 |
Why?
| Veterans | 2 | 2021 | 560 | 0.240 |
Why?
| Protein Processing, Post-Translational | 3 | 2012 | 171 | 0.240 |
Why?
| Chironomidae | 1 | 2004 | 1 | 0.240 |
Why?
| Ferrochelatase | 1 | 2004 | 1 | 0.240 |
Why?
| Aqueous Humor | 1 | 2024 | 10 | 0.240 |
Why?
| Retinal Artery Occlusion | 1 | 2024 | 13 | 0.240 |
Why?
| NF-kappa B | 1 | 2006 | 315 | 0.240 |
Why?
| Structure-Activity Relationship | 5 | 2022 | 401 | 0.240 |
Why?
| Butter | 2 | 2021 | 4 | 0.230 |
Why?
| Copper | 1 | 2004 | 43 | 0.230 |
Why?
| Nanoparticles | 2 | 2016 | 152 | 0.230 |
Why?
| Proteome | 1 | 2006 | 173 | 0.230 |
Why?
| Pyridines | 2 | 2023 | 131 | 0.230 |
Why?
| Glycyrrhiza | 1 | 2003 | 4 | 0.230 |
Why?
| Drug Discovery | 2 | 2021 | 88 | 0.230 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2003 | 62 | 0.230 |
Why?
| Proteins | 2 | 2006 | 345 | 0.220 |
Why?
| Disease Models, Animal | 3 | 2024 | 1458 | 0.220 |
Why?
| Binding Sites | 2 | 2022 | 375 | 0.220 |
Why?
| Hormones | 1 | 2023 | 57 | 0.220 |
Why?
| Tumor Suppressor Proteins | 2 | 2020 | 128 | 0.210 |
Why?
| Antineoplastic Agents, Phytogenic | 3 | 2016 | 70 | 0.210 |
Why?
| Methylcholanthrene | 1 | 2002 | 10 | 0.200 |
Why?
| Neoplasm Invasiveness | 2 | 2014 | 266 | 0.200 |
Why?
| Sp3 Transcription Factor | 1 | 2022 | 5 | 0.200 |
Why?
| RNA Polymerase II | 1 | 2022 | 12 | 0.200 |
Why?
| Infertility, Male | 1 | 2021 | 12 | 0.200 |
Why?
| Aminoquinolines | 1 | 2021 | 7 | 0.200 |
Why?
| Plant Extracts | 1 | 2003 | 171 | 0.190 |
Why?
| Phthalazines | 1 | 2021 | 20 | 0.190 |
Why?
| Thiophenes | 1 | 2021 | 36 | 0.190 |
Why?
| Disease Susceptibility | 2 | 2012 | 89 | 0.190 |
Why?
| Proteomics | 1 | 2024 | 330 | 0.190 |
Why?
| Forkhead Transcription Factors | 2 | 2012 | 112 | 0.190 |
Why?
| Computational Biology | 3 | 2019 | 216 | 0.190 |
Why?
| Glucuronosyltransferase | 1 | 2002 | 124 | 0.190 |
Why?
| Dietary Fats | 1 | 2021 | 124 | 0.190 |
Why?
| Risk | 3 | 2017 | 324 | 0.190 |
Why?
| Ovarian Neoplasms | 1 | 2005 | 447 | 0.190 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 143 | 0.180 |
Why?
| Transforming Growth Factor beta | 1 | 2021 | 144 | 0.180 |
Why?
| DNA Modification Methylases | 1 | 2020 | 28 | 0.180 |
Why?
| Isocitrate Dehydrogenase | 1 | 2020 | 17 | 0.180 |
Why?
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 42 | 0.180 |
Why?
| Estrogen Receptor alpha | 3 | 2019 | 89 | 0.180 |
Why?
| DNA Repair Enzymes | 1 | 2020 | 44 | 0.180 |
Why?
| Pyruvate Kinase | 1 | 2020 | 7 | 0.180 |
Why?
| Pyrroles | 1 | 2020 | 69 | 0.180 |
Why?
| Molecular Sequence Data | 4 | 2006 | 793 | 0.180 |
Why?
| Hair | 2 | 2018 | 30 | 0.180 |
Why?
| Sequence Analysis, RNA | 1 | 2020 | 91 | 0.170 |
Why?
| Random Allocation | 2 | 2017 | 282 | 0.170 |
Why?
| Drug Design | 1 | 2020 | 121 | 0.170 |
Why?
| Up-Regulation | 3 | 2019 | 453 | 0.170 |
Why?
| Pharyngeal Neoplasms | 1 | 2019 | 2 | 0.170 |
Why?
| Glioma | 1 | 2020 | 79 | 0.170 |
Why?
| Mouth Neoplasms | 1 | 2019 | 20 | 0.170 |
Why?
| Endometrial Neoplasms | 1 | 2020 | 138 | 0.170 |
Why?
| Collagen Type III | 1 | 2019 | 7 | 0.170 |
Why?
| Subcellular Fractions | 2 | 2012 | 34 | 0.170 |
Why?
| Amino Acid Sequence | 3 | 2006 | 586 | 0.160 |
Why?
| Liver Failure, Acute | 1 | 2019 | 54 | 0.160 |
Why?
| Stress, Psychological | 1 | 2020 | 261 | 0.160 |
Why?
| Military Personnel | 1 | 2020 | 161 | 0.160 |
Why?
| Tissue Array Analysis | 3 | 2016 | 45 | 0.160 |
Why?
| Anxiety | 1 | 2020 | 275 | 0.160 |
Why?
| Methylmercury Compounds | 1 | 2018 | 5 | 0.160 |
Why?
| Collagen Type I | 1 | 2019 | 88 | 0.160 |
Why?
| Denmark | 1 | 2018 | 45 | 0.160 |
Why?
| Polychlorinated Biphenyls | 1 | 2018 | 24 | 0.160 |
Why?
| Pregnancy in Diabetics | 1 | 2018 | 29 | 0.150 |
Why?
| Depressive Disorder | 1 | 2020 | 339 | 0.150 |
Why?
| Fetal Blood | 1 | 2018 | 69 | 0.150 |
Why?
| Water Pollutants, Chemical | 1 | 2018 | 42 | 0.150 |
Why?
| Histone Demethylases | 1 | 2017 | 16 | 0.150 |
Why?
| Receptors, Aryl Hydrocarbon | 1 | 2017 | 25 | 0.150 |
Why?
| Urethane | 1 | 2017 | 6 | 0.150 |
Why?
| Infant, Newborn | 3 | 2023 | 2766 | 0.150 |
Why?
| Neoplasms | 2 | 2005 | 1249 | 0.150 |
Why?
| Pneumonia, Viral | 1 | 2020 | 169 | 0.150 |
Why?
| Coronavirus Infections | 1 | 2020 | 178 | 0.140 |
Why?
| Cells, Cultured | 4 | 2019 | 1581 | 0.140 |
Why?
| Protein Binding | 2 | 2011 | 665 | 0.140 |
Why?
| Mammary Glands, Animal | 1 | 2017 | 69 | 0.140 |
Why?
| Research Design | 1 | 2019 | 342 | 0.140 |
Why?
| Fibroblasts | 1 | 2019 | 351 | 0.140 |
Why?
| Gene Expression | 2 | 2018 | 609 | 0.140 |
Why?
| Cholesterol | 1 | 2017 | 147 | 0.140 |
Why?
| Brain Neoplasms | 1 | 2020 | 288 | 0.140 |
Why?
| Sex Characteristics | 1 | 2018 | 191 | 0.140 |
Why?
| 5-Methylcytosine | 1 | 2016 | 16 | 0.140 |
Why?
| Immunohistochemistry | 4 | 2016 | 978 | 0.140 |
Why?
| Rats, Sprague-Dawley | 5 | 2021 | 1586 | 0.140 |
Why?
| Placenta | 1 | 2018 | 132 | 0.140 |
Why?
| Heart Diseases | 1 | 2019 | 211 | 0.140 |
Why?
| Carcinoma, Squamous Cell | 1 | 2019 | 318 | 0.130 |
Why?
| Paclitaxel | 1 | 2016 | 84 | 0.130 |
Why?
| Environmental Health | 1 | 2016 | 12 | 0.130 |
Why?
| Adult | 8 | 2020 | 13324 | 0.130 |
Why?
| Membrane Proteins | 2 | 2010 | 353 | 0.130 |
Why?
| Myocardium | 1 | 2019 | 438 | 0.130 |
Why?
| Sexual Maturation | 1 | 2015 | 14 | 0.130 |
Why?
| Reproduction | 1 | 2016 | 61 | 0.130 |
Why?
| Embryo Implantation | 1 | 2015 | 7 | 0.130 |
Why?
| Embryonic Development | 1 | 2015 | 17 | 0.130 |
Why?
| Pandemics | 1 | 2020 | 562 | 0.130 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2016 | 53 | 0.130 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2016 | 106 | 0.130 |
Why?
| Interferons | 1 | 2015 | 38 | 0.130 |
Why?
| Myeloid Cells | 1 | 2015 | 38 | 0.130 |
Why?
| RNA, Untranslated | 1 | 2015 | 14 | 0.130 |
Why?
| Prostatectomy | 1 | 2016 | 81 | 0.130 |
Why?
| Histone Code | 1 | 2015 | 32 | 0.130 |
Why?
| Polyglycolic Acid | 1 | 2015 | 6 | 0.130 |
Why?
| Histidine | 1 | 2015 | 15 | 0.130 |
Why?
| Chemistry, Pharmaceutical | 1 | 2015 | 33 | 0.130 |
Why?
| Aged | 7 | 2024 | 9405 | 0.120 |
Why?
| Particle Size | 1 | 2015 | 80 | 0.120 |
Why?
| Tumor Cells, Cultured | 3 | 2022 | 468 | 0.120 |
Why?
| Image Processing, Computer-Assisted | 1 | 2016 | 246 | 0.120 |
Why?
| Receptor, erbB-2 | 1 | 2015 | 74 | 0.120 |
Why?
| Inflammasomes | 1 | 2015 | 59 | 0.120 |
Why?
| Drug Carriers | 1 | 2015 | 71 | 0.120 |
Why?
| Lysosomes | 1 | 2015 | 84 | 0.120 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2014 | 47 | 0.120 |
Why?
| Polyethylene Glycols | 1 | 2015 | 93 | 0.120 |
Why?
| Lactic Acid | 1 | 2015 | 76 | 0.120 |
Why?
| HMGA Proteins | 1 | 2014 | 2 | 0.120 |
Why?
| Base Sequence | 3 | 2005 | 644 | 0.120 |
Why?
| Caspase 7 | 1 | 2013 | 6 | 0.120 |
Why?
| Isoenzymes | 2 | 2005 | 169 | 0.120 |
Why?
| Kaplan-Meier Estimate | 2 | 2017 | 465 | 0.110 |
Why?
| MCF-7 Cells | 1 | 2013 | 69 | 0.110 |
Why?
| Middle Aged | 7 | 2024 | 12206 | 0.110 |
Why?
| Histones | 2 | 2015 | 313 | 0.110 |
Why?
| 5' Untranslated Regions | 1 | 2013 | 31 | 0.110 |
Why?
| Repressor Proteins | 1 | 2014 | 153 | 0.110 |
Why?
| Histone Acetyltransferases | 1 | 2013 | 22 | 0.110 |
Why?
| Open Reading Frames | 1 | 2013 | 55 | 0.110 |
Why?
| Drug Delivery Systems | 1 | 2015 | 146 | 0.110 |
Why?
| Vehicle Emissions | 1 | 2012 | 10 | 0.110 |
Why?
| Estrogens, Non-Steroidal | 2 | 2015 | 16 | 0.110 |
Why?
| DNA | 1 | 2016 | 541 | 0.110 |
Why?
| Transcriptome | 1 | 2015 | 320 | 0.110 |
Why?
| Models, Biological | 2 | 2017 | 723 | 0.110 |
Why?
| Genetic Predisposition to Disease | 1 | 2015 | 509 | 0.100 |
Why?
| Air Pollutants | 1 | 2012 | 60 | 0.100 |
Why?
| RNA Splicing | 1 | 2012 | 37 | 0.100 |
Why?
| Doxorubicin | 1 | 2013 | 239 | 0.100 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 83 | 0.100 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 486 | 0.100 |
Why?
| Cisplatin | 1 | 2013 | 278 | 0.100 |
Why?
| Diet | 1 | 2015 | 557 | 0.100 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 96 | 0.100 |
Why?
| Antibodies | 1 | 2012 | 154 | 0.100 |
Why?
| Risk Factors | 3 | 2020 | 3629 | 0.100 |
Why?
| MAP Kinase Signaling System | 1 | 2012 | 118 | 0.100 |
Why?
| Protein Biosynthesis | 1 | 2013 | 254 | 0.090 |
Why?
| Kruppel-Like Transcription Factors | 1 | 2011 | 36 | 0.090 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 595 | 0.090 |
Why?
| Racemases and Epimerases | 1 | 2011 | 15 | 0.090 |
Why?
| Cell Cycle | 1 | 2012 | 232 | 0.090 |
Why?
| Cell Transformation, Neoplastic | 2 | 2017 | 179 | 0.090 |
Why?
| Models, Genetic | 1 | 2011 | 170 | 0.090 |
Why?
| Cell Nucleus | 2 | 2016 | 187 | 0.090 |
Why?
| Molecular Structure | 2 | 2021 | 296 | 0.090 |
Why?
| Introns | 1 | 2010 | 48 | 0.090 |
Why?
| Testosterone | 2 | 2016 | 140 | 0.090 |
Why?
| Gene Expression Regulation | 3 | 2015 | 979 | 0.090 |
Why?
| Carcinogens | 2 | 2015 | 198 | 0.090 |
Why?
| Gene Silencing | 1 | 2010 | 118 | 0.090 |
Why?
| Manganese Poisoning | 1 | 2009 | 5 | 0.090 |
Why?
| Disease-Free Survival | 1 | 2010 | 454 | 0.080 |
Why?
| Proportional Hazards Models | 1 | 2010 | 410 | 0.080 |
Why?
| Asthma | 1 | 2012 | 280 | 0.080 |
Why?
| Oligonucleotide Array Sequence Analysis | 3 | 2007 | 411 | 0.080 |
Why?
| Methylation | 2 | 2020 | 123 | 0.080 |
Why?
| Community-Based Participatory Research | 1 | 2009 | 200 | 0.070 |
Why?
| Enzyme Activation | 2 | 2006 | 275 | 0.070 |
Why?
| Sequence Analysis, DNA | 2 | 2019 | 238 | 0.070 |
Why?
| Apigenin | 1 | 2006 | 5 | 0.070 |
Why?
| Estrogen Receptor Modulators | 1 | 2006 | 5 | 0.070 |
Why?
| Presenilin-2 | 1 | 2006 | 3 | 0.070 |
Why?
| Yeasts | 1 | 2006 | 10 | 0.070 |
Why?
| Sequence Analysis, Protein | 1 | 2006 | 19 | 0.070 |
Why?
| Dimerization | 1 | 2006 | 50 | 0.070 |
Why?
| Growth Differentiation Factor 1 | 1 | 2006 | 2 | 0.070 |
Why?
| Interleukin-12 | 1 | 2006 | 31 | 0.070 |
Why?
| Sex Factors | 2 | 2019 | 697 | 0.070 |
Why?
| Cohort Studies | 1 | 2010 | 1422 | 0.070 |
Why?
| Receptor Protein-Tyrosine Kinases | 1 | 2006 | 51 | 0.070 |
Why?
| Interleukin-8 | 1 | 2006 | 86 | 0.070 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2006 | 105 | 0.060 |
Why?
| Benzo(a)pyrene | 1 | 2005 | 12 | 0.060 |
Why?
| Epithelium | 1 | 2005 | 65 | 0.060 |
Why?
| Models, Molecular | 1 | 2006 | 341 | 0.060 |
Why?
| Molecular Conformation | 1 | 2005 | 67 | 0.060 |
Why?
| Genes, p53 | 1 | 2005 | 51 | 0.060 |
Why?
| Alternative Splicing | 1 | 2005 | 56 | 0.060 |
Why?
| Genes, Tumor Suppressor | 1 | 2005 | 73 | 0.060 |
Why?
| Ovary | 1 | 2005 | 115 | 0.060 |
Why?
| Phosphopyruvate Hydratase | 1 | 2024 | 9 | 0.060 |
Why?
| Cations, Divalent | 1 | 2004 | 6 | 0.060 |
Why?
| Vitreous Body | 1 | 2024 | 19 | 0.060 |
Why?
| Iron-Sulfur Proteins | 1 | 2004 | 8 | 0.060 |
Why?
| Paracentesis | 1 | 2024 | 13 | 0.060 |
Why?
| Eye Proteins | 1 | 2024 | 17 | 0.060 |
Why?
| Metals | 1 | 2004 | 35 | 0.060 |
Why?
| Transfection | 1 | 2005 | 355 | 0.060 |
Why?
| Survival Analysis | 2 | 2016 | 666 | 0.060 |
Why?
| Sequence Alignment | 1 | 2004 | 122 | 0.060 |
Why?
| Cloning, Molecular | 1 | 2004 | 186 | 0.060 |
Why?
| Receptors, Urokinase Plasminogen Activator | 1 | 2003 | 2 | 0.060 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2003 | 6 | 0.060 |
Why?
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2003 | 13 | 0.060 |
Why?
| Glutathione S-Transferase pi | 1 | 2003 | 24 | 0.060 |
Why?
| Deoxyguanosine | 1 | 2003 | 27 | 0.060 |
Why?
| Cell Survival | 2 | 2021 | 602 | 0.060 |
Why?
| Blotting, Northern | 1 | 2003 | 109 | 0.060 |
Why?
| Clone Cells | 1 | 2003 | 78 | 0.060 |
Why?
| Vitrectomy | 1 | 2024 | 58 | 0.060 |
Why?
| Molecular Docking Simulation | 1 | 2023 | 75 | 0.060 |
Why?
| Transcription Factor AP-1 | 1 | 2003 | 63 | 0.060 |
Why?
| Pilot Projects | 2 | 2020 | 697 | 0.060 |
Why?
| Metabolome | 1 | 2023 | 89 | 0.050 |
Why?
| Glutathione Transferase | 1 | 2003 | 174 | 0.050 |
Why?
| Receptors, Cell Surface | 1 | 2003 | 125 | 0.050 |
Why?
| Young Adult | 3 | 2020 | 3981 | 0.050 |
Why?
| Kinetics | 1 | 2004 | 631 | 0.050 |
Why?
| Metabolomics | 1 | 2023 | 125 | 0.050 |
Why?
| Mice, Inbred C57BL | 2 | 2019 | 1819 | 0.050 |
Why?
| Herbal Medicine | 1 | 2002 | 3 | 0.050 |
Why?
| Dactinomycin | 1 | 2002 | 23 | 0.050 |
Why?
| Nucleic Acid Synthesis Inhibitors | 1 | 2002 | 15 | 0.050 |
Why?
| RNA Stability | 1 | 2002 | 24 | 0.050 |
Why?
| Inheritance Patterns | 1 | 2021 | 22 | 0.050 |
Why?
| Mitochondria | 1 | 2005 | 404 | 0.050 |
Why?
| Amino Acids | 1 | 2023 | 362 | 0.050 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2021 | 25 | 0.050 |
Why?
| Smad Proteins | 1 | 2021 | 11 | 0.050 |
Why?
| Incineration | 1 | 2021 | 5 | 0.050 |
Why?
| Prognosis | 2 | 2017 | 1954 | 0.050 |
Why?
| Testis | 1 | 2021 | 69 | 0.050 |
Why?
| Staining and Labeling | 2 | 2016 | 97 | 0.050 |
Why?
| Drug Screening Assays, Antitumor | 1 | 2021 | 140 | 0.050 |
Why?
| Phytoestrogens | 2 | 2014 | 22 | 0.050 |
Why?
| Drug Evaluation, Preclinical | 1 | 2021 | 143 | 0.050 |
Why?
| Maternal Nutritional Physiological Phenomena | 1 | 2021 | 57 | 0.050 |
Why?
| Loneliness | 1 | 2020 | 11 | 0.050 |
Why?
| Small Molecule Libraries | 1 | 2021 | 68 | 0.050 |
Why?
| Hypesthesia | 1 | 2020 | 17 | 0.050 |
Why?
| Chemistry Techniques, Synthetic | 1 | 2020 | 20 | 0.050 |
Why?
| Alcohol Oxidoreductases | 1 | 2020 | 13 | 0.050 |
Why?
| Wound Healing | 1 | 2022 | 205 | 0.050 |
Why?
| Memory Disorders | 1 | 2020 | 54 | 0.040 |
Why?
| Lymphangioleiomyomatosis | 1 | 2020 | 4 | 0.040 |
Why?
| Fear | 1 | 2020 | 83 | 0.040 |
Why?
| Hep G2 Cells | 1 | 2019 | 36 | 0.040 |
Why?
| Adaptation, Psychological | 1 | 2020 | 223 | 0.040 |
Why?
| Oxidative Stress | 1 | 2003 | 771 | 0.040 |
Why?
| Acetylcysteine | 1 | 2019 | 100 | 0.040 |
Why?
| Rats, Wistar | 1 | 2019 | 222 | 0.040 |
Why?
| Cross-Sectional Studies | 1 | 2023 | 1554 | 0.040 |
Why?
| Linear Models | 1 | 2019 | 278 | 0.040 |
Why?
| Fibrosis | 1 | 2019 | 180 | 0.040 |
Why?
| Biopsy | 1 | 2020 | 590 | 0.040 |
Why?
| Aging | 1 | 2003 | 688 | 0.040 |
Why?
| Diet, Atherogenic | 1 | 2017 | 8 | 0.040 |
Why?
| Injections, Intraperitoneal | 1 | 2017 | 55 | 0.040 |
Why?
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 40 | 0.040 |
Why?
| Calcium Phosphates | 1 | 2016 | 5 | 0.030 |
Why?
| Gene Regulatory Networks | 1 | 2017 | 107 | 0.030 |
Why?
| Polymers | 1 | 2016 | 41 | 0.030 |
Why?
| Exercise | 1 | 2020 | 503 | 0.030 |
Why?
| Genetic Loci | 1 | 2016 | 49 | 0.030 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 170 | 0.030 |
Why?
| Acetaminophen | 1 | 2019 | 283 | 0.030 |
Why?
| Lung | 1 | 2020 | 490 | 0.030 |
Why?
| Age Factors | 2 | 2014 | 1092 | 0.030 |
Why?
| Ethinyl Estradiol | 1 | 2015 | 8 | 0.030 |
Why?
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2015 | 50 | 0.030 |
Why?
| Environment | 1 | 2016 | 83 | 0.030 |
Why?
| Models, Theoretical | 1 | 2016 | 174 | 0.030 |
Why?
| Sp Transcription Factors | 1 | 2014 | 6 | 0.030 |
Why?
| Pentacyclic Triterpenes | 1 | 2014 | 8 | 0.030 |
Why?
| Lupus Erythematosus, Systemic | 1 | 2015 | 69 | 0.030 |
Why?
| Cluster Analysis | 1 | 2015 | 235 | 0.030 |
Why?
| Triterpenes | 1 | 2014 | 11 | 0.030 |
Why?
| Neoplasm Transplantation | 1 | 2014 | 85 | 0.030 |
Why?
| Lysine | 1 | 2015 | 89 | 0.030 |
Why?
| Transplantation, Heterologous | 1 | 2014 | 75 | 0.030 |
Why?
| Schools | 1 | 2016 | 165 | 0.030 |
Why?
| Case-Control Studies | 1 | 2018 | 1126 | 0.030 |
Why?
| Gestational Age | 1 | 2016 | 418 | 0.030 |
Why?
| Immunity, Innate | 1 | 2015 | 105 | 0.030 |
Why?
| Mice, Nude | 1 | 2014 | 254 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 181 | 0.030 |
Why?
| Stem Cells | 1 | 2015 | 171 | 0.030 |
Why?
| Epithelial Cells | 1 | 2015 | 207 | 0.030 |
Why?
| Genome | 1 | 2014 | 65 | 0.030 |
Why?
| Blotting, Western | 1 | 2014 | 601 | 0.030 |
Why?
| Acetylation | 1 | 2013 | 97 | 0.030 |
Why?
| Life Style | 1 | 2014 | 141 | 0.030 |
Why?
| Infant | 2 | 2012 | 3563 | 0.030 |
Why?
| Saliva | 1 | 2012 | 55 | 0.030 |
Why?
| Child, Preschool | 2 | 2012 | 3883 | 0.030 |
Why?
| Reproducibility of Results | 1 | 2016 | 1185 | 0.030 |
Why?
| Cell Line | 1 | 2015 | 1021 | 0.030 |
Why?
| Neoplasm Recurrence, Local | 1 | 2016 | 613 | 0.020 |
Why?
| Adolescent | 2 | 2016 | 6390 | 0.020 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2018 | 486 | 0.020 |
Why?
| Nerve Tissue Proteins | 1 | 2013 | 193 | 0.020 |
Why?
| Carrier Proteins | 1 | 2013 | 306 | 0.020 |
Why?
| In Situ Hybridization | 1 | 2010 | 65 | 0.020 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 73 | 0.020 |
Why?
| Hemochromatosis | 1 | 2009 | 3 | 0.020 |
Why?
| Ohio | 1 | 2009 | 39 | 0.020 |
Why?
| Antigens, Surface | 1 | 2009 | 54 | 0.020 |
Why?
| Manganese | 1 | 2009 | 23 | 0.020 |
Why?
| Statistics as Topic | 1 | 2009 | 87 | 0.020 |
Why?
| Obesity | 1 | 2018 | 1108 | 0.020 |
Why?
| Child | 2 | 2012 | 6851 | 0.020 |
Why?
| Dihydrotestosterone | 1 | 2007 | 12 | 0.020 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2009 | 485 | 0.020 |
Why?
| Anticarcinogenic Agents | 1 | 2006 | 32 | 0.020 |
Why?
| Caspase 3 | 1 | 2006 | 97 | 0.020 |
Why?
| Down-Regulation | 1 | 2007 | 349 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2006 | 215 | 0.020 |
Why?
| TATA Box | 1 | 2004 | 9 | 0.020 |
Why?
| Dinucleoside Phosphates | 1 | 2004 | 6 | 0.020 |
Why?
| DNA Primers | 1 | 2004 | 207 | 0.010 |
Why?
| Orchiectomy | 1 | 2003 | 41 | 0.010 |
Why?
| Rats, Inbred Strains | 1 | 2003 | 194 | 0.010 |
Why?
| Retrospective Studies | 1 | 2016 | 6134 | 0.010 |
Why?
| Oxidoreductases | 1 | 2003 | 60 | 0.010 |
Why?
| Precancerous Conditions | 1 | 2004 | 83 | 0.010 |
Why?
| Peptide Elongation Factor 1 | 1 | 2003 | 2 | 0.010 |
Why?
| Aldehydes | 1 | 2003 | 83 | 0.010 |
Why?
| Clusterin | 1 | 2003 | 6 | 0.010 |
Why?
| Neoplasm Metastasis | 1 | 2004 | 236 | 0.010 |
Why?
| Amino Acyl-tRNA Synthetases | 1 | 2003 | 6 | 0.010 |
Why?
| Postoperative Period | 1 | 2003 | 168 | 0.010 |
Why?
| Cytoskeleton | 1 | 2003 | 41 | 0.010 |
Why?
| Regeneration | 1 | 2003 | 72 | 0.010 |
Why?
| Molecular Chaperones | 1 | 2003 | 65 | 0.010 |
Why?
| Alkaline Phosphatase | 1 | 2003 | 95 | 0.010 |
Why?
| Glycoproteins | 1 | 2003 | 117 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2009 | 3154 | 0.010 |
Why?
| Membrane Glycoproteins | 1 | 2003 | 246 | 0.010 |
Why?
| Neoplasm Staging | 1 | 2004 | 738 | 0.010 |
Why?
|
|
Leung's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|